What's breaking now, across thousands of outlets.
After 37 years, Frank Bennett is retiring from Ionis Pharmaceuticals. Bennett started at Ionis as a founding scientist in 1989 and climbed to the role of CSO. Bennett will retire in February 2027, Ionis
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Death toll rises to 54, cases surpass 15,300
Karyopharm’s stock has plummeted after its second attempt to expand its blood cancer medicine Xpovio into endometrial cancer fell short.
It’s a little more complicated than that
Machine learning decodes the complex chemical signatures in human breath to deliver rapid, non-invasive tuberculosis diagnoses The post AI sniffs out tuberculosis in breath’s chemical signature…
[Liberian Observer] For hundreds of residents from more than thirty communities along the Roberts International Airport (RIA) Highway, a routine medical check-up is often a luxury rather than a…
Braintree founder Johnson became the subject of many household conversations after appearing in the Netflix documentary Don't Die: The Man Who Wants to Live Forever.
